Bo Yu

机构：Pudong Medical Center, Huashan Hospital · ORCID：0000-0002-7520-453X

发表论文 60 篇 · 总被引 1005 次 · h-index 16

代表论文

• BCMA-targeted immunotherapy for multiple myeloma (2020 · Journal of Hematology & Oncology · 被引 234)
• Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice (2021 · European Journal of Cancer · 被引 65)
• Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study (2020 · Journal for ImmunoTherapy of Cancer · 被引 62)
• Empiric use of anticoagulation in hospitalized patients with COVID-19: a propensity score-matched study of risks and benefits (2021 · Biomarker Research · 被引 37)
• Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy (2020 · Journal for ImmunoTherapy of Cancer · 被引 36)
• Performance of Management Strategies With Class I Recommendations Among Patients Hospitalized With ST-Segment Elevation Myocardial Infarction in China (2022 · JAMA Cardiology · 被引 32)